ARTG Entry

CAPRELSA

ARTG entry for CAPRELSA (vandetanib), ARTG 192496 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Sanofi-Aventis
• Active ingredient: vandetanib
• Therapeutic area: Oncology

TGA Public Summary — ARTG 192496